 Michelle Leppert
Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 16 | 2024 | 1016 | 4.210 |
Why?
| | Neurology | 2 | 2023 | 85 | 1.540 |
Why?
| | Brain Ischemia | 6 | 2022 | 298 | 1.520 |
Why?
| | Hospitalists | 2 | 2023 | 173 | 1.300 |
Why?
| | Foramen Ovale, Patent | 3 | 2024 | 44 | 1.020 |
Why?
| | Cost-Benefit Analysis | 2 | 2018 | 548 | 0.920 |
Why?
| | Inpatients | 2 | 2022 | 380 | 0.740 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2020 | 45 | 0.700 |
Why?
| | Aftercare | 1 | 2020 | 187 | 0.620 |
Why?
| | Secondary Prevention | 2 | 2024 | 223 | 0.610 |
Why?
| | Nutrition Surveys | 1 | 2019 | 225 | 0.600 |
Why?
| | Sinus Thrombosis, Intracranial | 1 | 2017 | 22 | 0.570 |
Why?
| | Ambulatory Care | 1 | 2020 | 478 | 0.540 |
Why?
| | Heart Septal Defects, Atrial | 1 | 2016 | 51 | 0.510 |
Why?
| | Atherosclerosis | 1 | 2019 | 341 | 0.500 |
Why?
| | Patient Readmission | 1 | 2020 | 609 | 0.480 |
Why?
| | Risk Assessment | 2 | 2022 | 2987 | 0.450 |
Why?
| | Endovascular Procedures | 1 | 2017 | 269 | 0.440 |
Why?
| | Tissue Plasminogen Activator | 1 | 2015 | 228 | 0.430 |
Why?
| | Incidence | 4 | 2022 | 2335 | 0.350 |
Why?
| | Disability Evaluation | 2 | 2021 | 271 | 0.310 |
Why?
| | Humans | 24 | 2024 | 115587 | 0.300 |
Why?
| | Mycosis Fungoides | 2 | 2018 | 61 | 0.280 |
Why?
| | Follow-Up Studies | 3 | 2020 | 4440 | 0.260 |
Why?
| | Retrospective Studies | 7 | 2022 | 12608 | 0.250 |
Why?
| | Young Adult | 5 | 2022 | 10470 | 0.250 |
Why?
| | Female | 12 | 2023 | 59913 | 0.230 |
Why?
| | Embolism | 1 | 2023 | 43 | 0.220 |
Why?
| | Sex Characteristics | 3 | 2023 | 641 | 0.220 |
Why?
| | Male | 13 | 2023 | 55949 | 0.220 |
Why?
| | Carotid Stenosis | 1 | 2023 | 78 | 0.210 |
Why?
| | Middle Aged | 9 | 2021 | 26999 | 0.210 |
Why?
| | Thromboembolism | 1 | 2023 | 93 | 0.210 |
Why?
| | Risk Factors | 4 | 2022 | 8697 | 0.200 |
Why?
| | Adult | 7 | 2022 | 30718 | 0.190 |
Why?
| | Aged, 80 and over | 4 | 2020 | 6417 | 0.190 |
Why?
| | Personal Protective Equipment | 1 | 2021 | 50 | 0.180 |
Why?
| | Cerebrovascular Disorders | 1 | 2021 | 82 | 0.180 |
Why?
| | Cerebral Angiography | 1 | 2020 | 111 | 0.180 |
Why?
| | Cohort Studies | 2 | 2020 | 4944 | 0.180 |
Why?
| | Thrombectomy | 1 | 2020 | 53 | 0.180 |
Why?
| | Age Distribution | 1 | 2020 | 341 | 0.170 |
Why?
| | Sex Distribution | 1 | 2020 | 337 | 0.170 |
Why?
| | Skin Neoplasms | 2 | 2018 | 761 | 0.170 |
Why?
| | Sex Factors | 2 | 2022 | 1736 | 0.170 |
Why?
| | Aged | 5 | 2020 | 19251 | 0.170 |
Why?
| | Pregnant Women | 1 | 2020 | 132 | 0.160 |
Why?
| | Cardiac Catheterization | 2 | 2024 | 536 | 0.160 |
Why?
| | Brain Neoplasms | 2 | 2018 | 980 | 0.160 |
Why?
| | Health Status Disparities | 1 | 2021 | 204 | 0.160 |
Why?
| | Cerebral Arterial Diseases | 1 | 2019 | 42 | 0.160 |
Why?
| | Neurologic Examination | 1 | 2019 | 116 | 0.160 |
Why?
| | Length of Stay | 1 | 2023 | 958 | 0.160 |
Why?
| | Hospitals | 1 | 2023 | 585 | 0.160 |
Why?
| | Machine Learning | 1 | 2021 | 321 | 0.150 |
Why?
| | Age Factors | 2 | 2022 | 2907 | 0.150 |
Why?
| | Dura Mater | 1 | 2017 | 28 | 0.140 |
Why?
| | Public Health | 1 | 2020 | 438 | 0.130 |
Why?
| | Healthcare Disparities | 1 | 2021 | 485 | 0.130 |
Why?
| | Infusions, Intra-Arterial | 1 | 2015 | 45 | 0.130 |
Why?
| | Proportional Hazards Models | 1 | 2018 | 1087 | 0.120 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1127 | 0.120 |
Why?
| | Infusions, Intravenous | 1 | 2015 | 374 | 0.120 |
Why?
| | Global Health | 1 | 2016 | 290 | 0.110 |
Why?
| | United States | 2 | 2020 | 12295 | 0.110 |
Why?
| | Eosinophilia | 1 | 2015 | 186 | 0.110 |
Why?
| | Anticoagulants | 1 | 2017 | 549 | 0.110 |
Why?
| | Adolescent | 3 | 2022 | 17889 | 0.110 |
Why?
| | Pandemics | 1 | 2021 | 1334 | 0.110 |
Why?
| | Prevalence | 1 | 2019 | 2264 | 0.110 |
Why?
| | Hospitalization | 1 | 2021 | 1765 | 0.100 |
Why?
| | Decision Support Techniques | 1 | 2015 | 353 | 0.100 |
Why?
| | Emergency Service, Hospital | 1 | 2021 | 1829 | 0.090 |
Why?
| | Treatment Outcome | 2 | 2024 | 9159 | 0.080 |
Why?
| | Pregnancy | 1 | 2020 | 5548 | 0.080 |
Why?
| | Fatal Outcome | 2 | 2018 | 286 | 0.070 |
Why?
| | Predictive Value of Tests | 2 | 2021 | 1805 | 0.060 |
Why?
| | Circle of Willis | 1 | 2023 | 6 | 0.060 |
Why?
| | Cerebral Arteries | 1 | 2023 | 55 | 0.050 |
Why?
| | Middle Cerebral Artery | 1 | 2022 | 30 | 0.050 |
Why?
| | Infarction, Middle Cerebral Artery | 1 | 2022 | 38 | 0.050 |
Why?
| | Prognosis | 2 | 2021 | 3339 | 0.050 |
Why?
| | Carotid Arteries | 1 | 2023 | 183 | 0.050 |
Why?
| | Cerebrovascular Circulation | 1 | 2023 | 202 | 0.050 |
Why?
| | Kentucky | 1 | 2020 | 35 | 0.040 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2024 | 399 | 0.040 |
Why?
| | Ohio | 1 | 2020 | 136 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2021 | 741 | 0.040 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 273 | 0.030 |
Why?
| | Interleukins | 1 | 1994 | 238 | 0.030 |
Why?
| | Exercise | 1 | 2022 | 1609 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 2800 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 1994 | 621 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2022 | 3069 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2578 | 0.020 |
Why?
| | Time Factors | 1 | 2020 | 6165 | 0.020 |
Why?
| | Child | 1 | 2022 | 18488 | 0.010 |
Why?
| | Interleukin-3 | 1 | 1994 | 23 | 0.010 |
Why?
| | Interleukin-9 | 1 | 1994 | 10 | 0.010 |
Why?
| | Chromosomes, Human, Pair 5 | 1 | 1994 | 24 | 0.010 |
Why?
| | Interleukin-4 | 1 | 1994 | 209 | 0.010 |
Why?
| | DNA Primers | 1 | 1994 | 514 | 0.010 |
Why?
| | Gene Frequency | 1 | 1994 | 485 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 1994 | 1000 | 0.010 |
Why?
| | Base Sequence | 1 | 1994 | 2114 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 1994 | 2790 | 0.010 |
Why?
|
|
Leppert's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|